FATE THERAPEUTICS INC (FATE)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 28, 2026
as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jun 30, 2026, FATE THERAPEUTICS INC reported revenue of $2.1M, net income of -$30.2M, and total assets of $260.1M. Every figure below is taken directly from FATE THERAPEUTICS INC's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2025 · as reported
- FY2016 revenue
- $4.4M
- FY2025 revenue
- $6.6M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $6.6M | -$136.3M |
| FY2024 | $13.6M | -$186.3M |
| FY2023 | $63.5M | -$160.9M |
| FY2022 | $96.3M | -$281.7M |
| FY2021 | $55.8M | -$212.2M |
| FY2020 | $31.4M | -$173.4M |
| FY2019 | $10.7M | -$98.1M |
| FY2018 | $4.7M | -$66.6M |
| FY2017 | $4.1M | -$43.0M |
| FY2016 | $4.4M | -$33.5M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Sep 28, 2026 | on EDGAR ↗ |
| 8-K | Aug 13, 2026 | on EDGAR ↗ |
| 10-Q | Aug 13, 2026 | on EDGAR ↗ |
| 8-K | Jun 15, 2026 | on EDGAR ↗ |
| 8-K | Jun 4, 2026 | on EDGAR ↗ |
| 10-Q | May 13, 2026 | on EDGAR ↗ |
| 8-K | May 13, 2026 | on EDGAR ↗ |
| DEF 14A | Apr 24, 2026 | on EDGAR ↗ |
| 8-K | Feb 26, 2026 | on EDGAR ↗ |
| 10-K | Feb 26, 2026 | on EDGAR ↗ |
Balance Sheet
as of Jun 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jun 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jun 30, 2026
| EPS (diluted) | $-0.25 | Earnings | source ↗ |
| EPS (basic) | $-0.25 | Earnings | source ↗ |
| Shares Outstanding | 119.8M | Entity | source ↗ |
| Cash from Operations | -$23.4M | Net | source ↗ |
| Cash from Financing | — | — | source ↗ |
| Cash from Investing | $14.6M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 4
- Net shares
- -137.3K
Restatement history
Point-in-timeNo material restatements detected across 342 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches FATE’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/FATE
MCP tool:
get_sec_fundamentals ticker=FATE - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/FATE/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=FATE as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/FATE/history
MCP tool:
get_fundamentals_history ticker=FATE - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/FATE
MCP tool:
get_financial_health ticker=FATE
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.